Safety and Efficacy of Bone Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence
In brief
A systematic review of the clinical evidence on bone marrow aspirate concentrate (BMAC) injections for hip osteoarthritis, drawing on a small number of studies. The authors report no adverse events and improvements in pain, function and quality of life in the short to medium term, but stress that larger, well-designed trials are needed before routine use.
Read the original paper (opens in a new tab)
Citation, as listed in the BMAC guidelines
16. Safety and Efficacy of Bone Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence. Indian Journal of Orthopaedics (Springer). 2024. https://link.springer.com/10.1007/s43465-024-01183-7
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the BMAC guidelines
- Exploring Bias Patterns in Systematic Reviews and Meta-Analyses of Bone Marrow Aspirate Concentrate2026
- Intra-articular Injections for Shoulder Arthritis in Adults: A Systematic Review2025
- Evaluating Clinical Outcomes of Recombinant Human Bone Morphogenetic Protein-2 with ECM and BMAC for Ankle Osteochondral Lesions with Subchondral Damage2025
- Centrifuge-Free Bone Marrow Aspirate Harvest for Orthopaedic Applications2025

